China Reassures Public On Usage Of Topical Ibuprofen
This article was originally published in PharmAsia News
Executive SummaryFollowing U.S. FDA's recent warning to eight U.S. manufacturers of topical ibuprofen, China's State FDA has given its assurance that according to China's safety data, the drug does not show serious adverse reactions other than itching, flush and rash
You may also be interested in...
Former Sandoz executive Hector Armando Kellum has admitted involvement in a US generic price-fixing conspiracy, the US Department of Justice has announced.
The last year of the run up to the full implementation of the MDR has been characterized by a flurry of new documents and measures, but industry is adamant that medtech is heading for a crisis that will impact industry and patients alike.